studies, and HRQoL research.Develop asset value assessments and economic value frameworks to support pricing, reimbursement, and access decisions.Shape and communicate compelling economic value stories for assigned assets and indications.Influence clinical development programs to ensure evidence generation plans address HTA and payer requirements, including evolving EU HTA needs.Contribute to global value dossiers and support affiliates in the development of robust market access and reimbursement strategies.Partner with cross-functional teams to deliver evidence generation initiatives such as patient preference studies, natural history studies, and other outcomes research programs.Provide HEOR expertise and guidance throughout the product lifecycle, helping translate evidence into successful access outcomes.Contribute to scientific publications, congress presentations, abstracts, posters, and external scientific engagement activities.Support innovation and continuous improvement by sharing best practices, methodologies, and emerging approaches across the HEOR community. For this role we’re looking for:Master’s degree or PhD in Health Economics, Outcomes Research, Market Access, Public Health, Epidemiology, Pharmacy, or a related discipline.Strong experience within HEOR, Market Access, Outcomes Research, or Health Economics in the pharmaceutical, biotechnology, or consulting sectors.Expertise in health economic modelling, cost-effectiveness analyses, budget impact modelling, and outcomes research methodologies.Experience supporting HTA submissions, reimbursement processes, and payer evidence requirements across multiple markets.Rare Disease experience is highly desirable.Experience working across regions or at a global/intercontinental level, with a strong understanding of diverse healthcare systems and payer environments. clinical and economic value of UCB’s therapies.This role offers a unique opportunity to influence development programs from early stages through commercialization, helping ensure that innovative therapies achieve successful patient access around the world.Who You’ll Work WithYou will work closely with colleagues across Health Economics & Outcomes Research, Market Access, Patient Evidence, Real World Evidence, Patient-Centered Outcomes Research, Biostatistics, Clinical Development, and Medical Affairs. You will also collaborate with affiliate teams, external experts, and research partners to generate evidence that supports access and reimbursement decisions globally.What You’ll DoSupport the development and execution of global HEOR and payer evidence strategies aligned with asset and market access objectives.Design and deliver HEOR studies and deliverables, including cost-effectiveness models, budget impact models, systematic literature reviews, indirect treatment comparisons, HCRU, About us UCB is a global biopharmaceutical company, focusing on neurology and immunology. We are over 9.000 people in all four corners of the globe, inspired by patients and driven by science. Why work with us? At UCB, we don’t just complete tasks, we create value. We aren’t afraid to push forward, collaborate, and innovate to make our mark for patients. We have a caring, supportive culture where everyone feels included, respected, and has equal opportunities to do their best work. We ‘go beyond’ to create value for our patients, and always with a human focus, whether that’s on our patients, our employees, or our planet. Working for us, you will discover a place where you can grow, and have the freedom to carve your own career path to achieve your full potential. At UCB, we’ve embraced a hybrid-first approach to work, bringing teams together in local hubs to foster collaborative curiosity. Unless expressly stated in the description or precluded by the
#J-18808-Ljbffr…